HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of Y-20811, a thromboxane synthetase inhibitor, on photochemically induced cerebral embolism in rabbits.

Abstract
The effect of Y-20811, a selective thromboxane A2 synthetase inhibitor, was investigated on cerebral embolism using a new model of embolic cerebral infarction in rabbits. Most of cerebral infarctions were observed in the hemisphere, ipsilateral to the irradiated carotid artery. Cerebral infarction, ranging from 0.2 to 1.0 mm in size, appeared only on the surface of the cortex. The platelet emboli were identified in the carotid artery and cortex arteriole by light microscopy. In our study, 83% of the control group had cerebral infarction. Y-20811 significantly suppressed the infarction number and the incidence at doses of 1 mg/kg and 10 mg/kg (p.o.), respectively. Aspirin significantly inhibited the infarction number at a dose of 10 mg/kg, but its inhibitory effect decreased at 30 mg/kg. Ticlopidine showed no effect even at a dose of 300 mg/kg. These results indicate that Y-20811 may be useful in preventing embolic cerebral infarction and transient ischemic attacks.
AuthorsM Fujimura, H Mikashima
JournalThrombosis research (Thromb Res) Vol. 70 Issue 3 Pg. 233-44 (May 01 1993) ISSN: 0049-3848 [Print] United States
PMID8327988 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Imidazoles
  • Rose Bengal
  • Y 20811
  • Thromboxane-A Synthase
  • Ticlopidine
  • Aspirin
Topics
  • Animals
  • Aspirin (therapeutic use)
  • Carotid Artery Thrombosis (chemically induced, complications)
  • Carotid Stenosis (complications)
  • Cerebral Infarction (etiology, pathology, prevention & control)
  • Disease Models, Animal
  • Imidazoles (pharmacology, therapeutic use)
  • Intracranial Embolism and Thrombosis (complications, drug therapy, pathology)
  • Ligation
  • Male
  • Photochemistry
  • Platelet Aggregation
  • Rabbits
  • Rose Bengal (radiation effects, toxicity)
  • Thromboxane-A Synthase (antagonists & inhibitors)
  • Ticlopidine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: